Literature DB >> 29291207

History and current trends in influenza virus infections with special reference to Sri Lanka.

R A M Rafeek1, M V M Divarathna1, F Noordeen1.   

Abstract

The World Health Organization (WHO) estimates that approximately one billion people are infected and up to 500,000 people die from influenza each year in the world. Influenza is considered to be the greatest killer of the human populations, due to the 1918 Spanish flu, which killed millions around the world. Despite the effective treatment available against influenza, it still contributes to significant morbidity and mortality. Currently circulating influenza strains in humans include influenza A (H1N1)pdm09, influenza A (H3N2) and influenza B viruses, (B/Victoria and B/Yamagata). Influenza has been prevalent in Sri Lanka from 1969, since then it continued to cause morbidity and mortality in children and adults. The current global influenza surveillance network monitors the global influenza activity through WHO collaborating centres. The Medical Research Institute monitors and diagnoses influenza cases in the country as part of the WHO network laboratories. Vaccinations to high risk groups and antiviral therapy for the successful prevention of influenza have been practiced in Sri Lanka. This review highlights the impact of influenza on public health in Sri Lanka including the historical aspects, current diagnostic practices and prevention approaches in high risk individuals in the country.

Entities:  

Keywords:  Influenza; Morbidity; Mortality; Prevention; Public health; Sri Lanka

Year:  2017        PMID: 29291207      PMCID: PMC5684991          DOI: 10.1007/s13337-017-0390-8

Source DB:  PubMed          Journal:  Virusdisease        ISSN: 2347-3584


  46 in total

Review 1.  Prevention and treatment of influenza.

Authors:  R B Couch
Journal:  N Engl J Med       Date:  2000-12-14       Impact factor: 91.245

Review 2.  Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis.

Authors:  Harish Nair; W Abdullah Brooks; Mark Katz; Anna Roca; James A Berkley; Shabir A Madhi; James Mark Simmerman; Aubree Gordon; Masatoki Sato; Stephen Howie; Anand Krishnan; Maurice Ope; Kim A Lindblade; Phyllis Carosone-Link; Marilla Lucero; Walter Ochieng; Laurie Kamimoto; Erica Dueger; Niranjan Bhat; Sirenda Vong; Evropi Theodoratou; Malinee Chittaganpitch; Osaretin Chimah; Angel Balmaseda; Philippe Buchy; Eva Harris; Valerie Evans; Masahiko Katayose; Bharti Gaur; Cristina O'Callaghan-Gordo; Doli Goswami; Wences Arvelo; Marietjie Venter; Thomas Briese; Rafal Tokarz; Marc-Alain Widdowson; Anthony W Mounts; Robert F Breiman; Daniel R Feikin; Keith P Klugman; Sonja J Olsen; Bradford D Gessner; Peter F Wright; Igor Rudan; Shobha Broor; Eric A F Simões; Harry Campbell
Journal:  Lancet       Date:  2011-11-10       Impact factor: 79.321

3.  Tracking the emergence of pandemic Influenza A/H1N1/2009 and its interaction with seasonal influenza viruses in Singapore.

Authors:  Julian W T Tang; Chun Kiat Lee; Hong Kai Lee; Tze Ping Loh; Lily Chiu; Paul A Tambyah; Evelyn S C Koay
Journal:  Ann Acad Med Singap       Date:  2010-04       Impact factor: 2.473

4.  Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials.

Authors:  M Elizabeth Halloran; Frederick G Hayden; Yang Yang; Ira M Longini; Arnold S Monto
Journal:  Am J Epidemiol       Date:  2006-11-06       Impact factor: 4.897

5.  The signature features of influenza pandemics--implications for policy.

Authors:  Mark A Miller; Cecile Viboud; Marta Balinska; Lone Simonsen
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

6.  The influenza viruses.

Authors:  H K K Perera; J S M Peiris
Journal:  Ceylon Med J       Date:  2015-03

7.  Influenza: its control in persons and populations.

Authors:  R B Couch; J A Kasel; W P Glezen; T R Cate; H R Six; L H Taber; A L Frank; S B Greenberg; J M Zahradnik; W A Keitel
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

8.  Pandemic influenza (H1N1) 2009 is associated with severe disease in India.

Authors:  Akhilesh C Mishra; Mandeep S Chadha; Manohar L Choudhary; Varsha A Potdar
Journal:  PLoS One       Date:  2010-05-07       Impact factor: 3.240

9.  Influenza pneumonia.

Authors:  Elina Lahti; Ville Peltola; Raimo Virkki; Olli Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2006-02       Impact factor: 2.129

10.  Monitoring avian influenza A(H7N9) virus through national influenza-like illness surveillance, China.

Authors:  Cuiling Xu; Fiona Havers; Lijie Wang; Tao Chen; Jinghong Shi; Dayan Wang; Jing Yang; Lei Yang; Marc-Alain Widdowson; Yuelong Shu
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

View more
  4 in total

1.  Influenza H1 Mosaic Hemagglutinin Vaccine Induces Broad Immunity and Protection in Mice.

Authors:  Brigette N Corder; Brianna L Bullard; Jennifer L DeBeauchamp; Natalia A Ilyushina; Richard J Webby; Eric A Weaver
Journal:  Vaccines (Basel)       Date:  2019-11-23

2.  In silico analysis and molecular characterization of Influenza A (H1N1) pdm09 virus circulating and causing major outbreaks in central India, 2009-2019.

Authors:  Arshi Siddiqui; Rashmi Chowdhary; Harjeet Singh Maan; Sudhir Kumar Goel; Nidhi Tripathi; Anil Prakash
Journal:  Iran J Microbiol       Date:  2020-10

3.  Clinical and epidemiological characteristics of influenza virus infection in hospitalized children with acute respiratory infections in Sri Lanka.

Authors:  Rukshan A M Rafeek; Maduja V M Divarathna; Adrian J Morel; Faseeha Noordeen
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

4.  Outbreak of severe acute respiratory infection in Southern Province, Sri Lanka in 2018: a cross-sectional study.

Authors:  Sky Vanderburg; Gaya Wijayaratne; Nayomi Danthanarayana; Jude Jayamaha; Bhagya Piyasiri; Chathurangi Halloluwa; Tianchen Sheng; Sujeewa Amarasena; Ruvini Kurukulasooriya; Bradly P Nicholson; Joseph S M Peiris; Gregory C Gray; Sunethra Gunasena; Ajith Nagahawatte; Champica K Bodinayake; Christopher W Woods; Vasantha Devasiri; L Gayani Tillekeratne
Journal:  BMJ Open       Date:  2020-11-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.